ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
37 hedge funds and large institutions have $17.9M invested in Anthera Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
83% less call options, than puts
Call options by funds: $8K | Put options by funds: $46K
Holders
37
Holding in Top 10
1
Calls
$8K
Puts
$46K
Top Buyers
| 1 | +$762K | |
| 2 | +$622K | |
| 3 | +$158K | |
| 4 |
SIM
Spark Investment Management
New York
|
+$104K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$89K |
Top Sellers
| 1 | -$1.87M | |
| 2 | -$476K | |
| 3 | -$192K | |
| 4 |
JG
Jefferies Group
New York
|
-$192K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$133K |